Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
IONIS PHARMACEUTICALS INC (IONS)
|
|
Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| 10-Q | 8-K | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
Cost of goods sold | 1.3% | 0.8% | 2.4% | 0.9% | 3.5% | 2.9% | 0.5% | 2.3% |
Gross profit | 98.7% | 99.2% | 97.6% | 99.1% | 96.5% | 97.1% | 99.5% | 97.7% |
Selling, general and administrative | 24.5% | 35.1% | | 21.5% | 25.3% | 24.0% | | 23.4% |
Research and development | | | | | | | | |
General and administrative | | | 31.6% | | | | 8.5% | |
EBITDA | -44.4% | -87.0% | -134.6% | -34.3% | -60.6% | -37.5% | 51.1% | -61.3% |
Depreciation | 2.8% | | 2.0% | 2.4% | 2.8% | 2.6% | 0.9% | 2.8% |
EBITA | -47.2% | -87.0% | -136.6% | -36.6% | -63.5% | -40.1% | 50.3% | -64.0% |
Amortization of intangibles | 0.7% | | 0.4% | 0.4% | 0.5% | 0.4% | 0.1% | 0.5% |
EBIT | -47.9% | -87.0% | -137.0% | -37.0% | -63.9% | -40.5% | 50.1% | -64.5% |
Pre-tax income | -41.1% | -86.3% | -29.2% | -29.2% | -76.9% | -45.1% | 51.1% | -62.9% |
Income taxes | 4.2% | 8.4% | 5.3% | 0.2% | 1.7% | 0.8% | 0.1% | -1.0% |
Net income | -45.3% | -94.7% | -34.5% | -29.4% | -78.6% | -45.9% | 51.0% | -62.0% |
|